ADPT vs ICLR
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ADPT · Adaptive Biotechnologies$27.98 ▲ 4.29%
ICLR · Icon PLC$204.74 ▲ 1.53%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ADPT +90.2%
- ICLR +29.8%
Head to head
| Metric | ADPT | ICLR |
|---|---|---|
| Price | $27.98 | $204.74 |
| Change today | ▲ 4.29% | ▲ 1.53% |
| Market cap | $4.53B | $15.34B |
| Return, 3 months | +9.9% | +23.3% |
| Return, year to date | +72.3% | +12.4% |
| Return, 1 year | +89.2% | +28.7% |
| P/E (TTM) | – | 35.5 |
| P/B | 25.7 | 1.7 |
| P/E percentile vs own 5y | 3rd | 39th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +21.5% | +1.2% |
| Net profit growth (YoY) | -56.1% | -64.3% |
| Gross margin | 75.6% | 23.9% |
| Operating margin | -12.2% | 10.1% |
| Net margin | -20.7% | 0.5% |
| Return on equity | -39.6% | 0.4% |
| Analyst target vs. price | +11.0% | +15.9% |
| Analyst buy share | 88% | 58% |
| RSI (14) | 57 | 66 |
| 30-day volatility | 62.5% | 59.3% |
| Max drawdown, 1 year | -39.3% | -60.5% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ICLR is the largest of the group by market value.
- ADPT has returned the most over the past year.
- ADPT is growing revenue fastest.
- ICLR keeps the most profit per dollar of sales.
- ICLR has been the calmest stock over the last 30 days.